650 related articles for article (PubMed ID: 25673984)
1. COPD: balancing oxidants and antioxidants.
Fischer BM; Voynow JA; Ghio AJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():261-76. PubMed ID: 25673984
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.
MacNee W
Proc Am Thorac Soc; 2005; 2(1):50-60. PubMed ID: 16113469
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and free radicals in COPD--implications and relevance for treatment.
Domej W; Oettl K; Renner W
Int J Chron Obstruct Pulmon Dis; 2014; 9():1207-24. PubMed ID: 25378921
[TBL] [Abstract][Full Text] [Related]
4. Oxidants and COPD.
MacNee W
Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):627-41. PubMed ID: 17305519
[TBL] [Abstract][Full Text] [Related]
5. Oxidants/antioxidants and COPD.
MacNee W
Chest; 2000 May; 117(5 Suppl 1):303S-17S. PubMed ID: 10843965
[TBL] [Abstract][Full Text] [Related]
6. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
Lin JL; Thomas PS
COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
[TBL] [Abstract][Full Text] [Related]
7. Comparison of oxidant/antioxidant balance in COPD and non-COPD smokers.
Aydemir Y; Aydemir Ö; Şengül A; Güngen AC; Çoban H; Taşdemir C; Düzenli H; Şehitoğulları A
Heart Lung; 2019; 48(6):566-569. PubMed ID: 31371032
[TBL] [Abstract][Full Text] [Related]
8. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.
MacNee W
Novartis Found Symp; 2001; 234():169-85; discussion 185-8. PubMed ID: 11199095
[TBL] [Abstract][Full Text] [Related]
9. The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease.
Białas AJ; Sitarek P; Miłkowska-Dymanowska J; Piotrowski WJ; Górski P
Oxid Med Cell Longev; 2016; 2016():7808576. PubMed ID: 28105251
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
Biswas S; Hwang JW; Kirkham PA; Rahman I
Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation.
Fischer BM; Pavlisko E; Voynow JA
Int J Chron Obstruct Pulmon Dis; 2011; 6():413-21. PubMed ID: 21857781
[TBL] [Abstract][Full Text] [Related]
12. Oxidants in asthma and in chronic obstructive pulmonary disease (COPD).
Psarras S; Caramori G; Contoli M; Papadopoulos N; Papi A
Curr Pharm Des; 2005; 11(16):2053-62. PubMed ID: 15974958
[TBL] [Abstract][Full Text] [Related]
13. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
Tse HN; Tseng CZ
Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant therapeutic advances in COPD.
Rahman I
Ther Adv Respir Dis; 2008 Dec; 2(6):351-74. PubMed ID: 19124382
[TBL] [Abstract][Full Text] [Related]
15. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.
Yao H; Rahman I
Toxicol Appl Pharmacol; 2011 Jul; 254(2):72-85. PubMed ID: 21296096
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
Kirkham P; Rahman I
Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant therapies in COPD.
Rahman I
Int J Chron Obstruct Pulmon Dis; 2006; 1(1):15-29. PubMed ID: 18046899
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant therapeutic targets in COPD.
Rahman I; Kilty I
Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
[TBL] [Abstract][Full Text] [Related]
19. Role of oxidants/antioxidants in smoking-induced lung diseases.
Rahman I; MacNee W
Free Radic Biol Med; 1996; 21(5):669-81. PubMed ID: 8891669
[TBL] [Abstract][Full Text] [Related]
20. Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.
Rahman I; Kinnula VL
Expert Rev Clin Pharmacol; 2012 May; 5(3):293-309. PubMed ID: 22697592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
